The effect of parasympathetic (with atropine) and beta-adrenergic (with pro-pranolol) blockade on fetal heart rate variability (HRV) was studied in 162 term fetal Wistar rats. Administration of 1.3 mg of atropine into the jugular vein of the female rat led to an identical decrease of the RR interval in adult rats and in fetuses (about 10%). Administration of 2 mg of propranolol caused a rise in the RR interval by 19 % in rats and by 7–9 % in fetuses. Overall HRV indices (RMSM, CV) decrease was more pronounced in adult rats than in fetuses. Upon simultaneous administration of both blocking agents the RR interval in adult rats did not differ from the control values; in fetuses it was reduced by 6%. In adult rats HRV indices decreased considerably (by 70%) and their values were within the limits of the estimation error; in fetuses, HRV indices were no higher than upon the administration of any of the blocking agents. Umbilical cord clamping caused a decrease of PO2 in brain tissue from 24.7 ± 1.7 to 4.7 ± 0.8 mm Hg within 15 min and led to an immediate increase of the RR interval and the HRV indices if blocking agents were not used. The administration of one or both blocking agents abolished the initial (during the first 7 min of asphyxia) increase of RMSM and CV. Thus, HRV in fetal rats depends to a great extent on the activity of the autonomic nervous system, though it is not fully determined by it. Acute asphyxia causes stimulation of the autonomic nervous system leading to fetal distress.

Keywords:
Heart rate variability, Asphyxia, Fetal rat, Parasympathetic blockade, Beta-adrenergic blockade
This content is only available via PDF.
© 1988 S. Karger AG, Basel
1988
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.